Quaker Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$559K Sell
466
-124
-21% -$127K 0.16% 36
2026
Q1
$542K Sell
590
-5
-0.8% -$5.07K 0.17% 34
2025
Q4
$640K Buy
595
+110
+23% +$105K 0.2% 31
2025
Q3
$370K Sell
485
-26
-5% -$19.3K 0.12% 42
2025
Q2
$398K Buy
+511
New +$397K 0.13% 42
2024
Q3
$344K Buy
+388
New +$349K 0.13% 42
2024
Q1
$303K Hold
389
0.12% 41
2023
Q4
$227K Buy
389
+1
+0.3% +$584 0.1% 47
2023
Q3
$209K Buy
+388
New +$200K 0.1% 43
2022
Q4
Sell
-842
Closed -$272K 43
2022
Q3
$272K Buy
+842
New +$267K 0.14% 32
2022
Q1
Sell
-896
Closed -$247K 52
2021
Q4
$247K Buy
+896
New +$227K 0.11% 44

Other funds holding LLY

Quaker Wealth Management's LLY Position: Q2 2026 in Review

Quaker Wealth Management reduced its Eli Lilly (LLY) stake by 21% in Q2 2026, selling an estimated $127K and leaving 466 shares worth $559K. The position accounts for 0.16% of the portfolio, ranked #36.

Quaker Wealth Management first reported a position in LLY in Q4 2021 and has held it in 11 quarters since. The position peaked at $640K in Q4 2025. 4,635 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Quaker Wealth Management held 466 shares of Eli Lilly worth $559K as of Q2 2026.
  • Quaker Wealth Management sold 124 Eli Lilly shares in Q2 2026, an estimated $127K.
  • Eli Lilly made up 0.16% of Quaker Wealth Management's portfolio in Q2 2026, its #36 holding.
  • Quaker Wealth Management first reported a position in Eli Lilly in Q4 2021 and has held it in 11 quarters since.
  • Quaker Wealth Management's Eli Lilly position peaked at $640K in Q4 2025.
  • 4,635 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Quaker Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.